Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales

Atherosclerosis
K HaralambosI F W McDowell

Abstract

Familial Hypercholesterolaemia (FH) is caused by mutations in genes of the Low Density Lipoprotein (LDL) receptor pathway. A definitive diagnosis of FH can be made by the demonstration of a pathogenic mutation. The Wales FH service has developed scoring criteria to guide selection of patients for DNA testing, for those referred to clinics with hypercholesterolaemia. The criteria are based on a modification of the Dutch Lipid Clinic scoring criteria and utilise a combination of lipid values, physical signs, personal and family history of premature cardiovascular disease. They are intended to provide clinical guidance and enable resources to be targeted in a cost effective manner. 623 patients who presented to lipid clinics across Wales had DNA testing following application of these criteria. The proportion of patients with a pathogenic mutation ranged from 4% in those scoring 5 or less up to 85% in those scoring 15 or more. LDL-cholesterol was the strongest discriminatory factor. Scores gained from physical signs, family history, coronary heart disease, and triglycerides also showed a gradient in mutation pick-up rate according to the score. These criteria provide a useful tool to guide selection of patients for DNA testing when...Continue Reading

References

Jan 4, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Steve E HumphriesAnthony S Wierzbicki
Oct 23, 2008·The American Journal of Cardiology·Fernando CiveiraMiguel Pocovi
Jul 9, 2010·Current Opinion in Lipidology·Borunendra N DattaAlan Rees
Jan 17, 2012·Atherosclerosis·Lourdes PalaciosMarianne Stef
Jul 4, 2012·BMJ : British Medical Journal·Susan MallettDouglas G Altman
Aug 16, 2012·The Journal of Clinical Endocrinology and Metabolism·Marianne BennBørge G Nordestgaard
Oct 26, 2012·Journal of Atherosclerosis and Thrombosis·Mariko Harada-ShibaShizuya Yamashita

❮ Previous
Next ❯

Citations

Jun 5, 2016·Mayo Clinic Proceedings·Maya S Safarova, Iftikhar J Kullo
Jul 9, 2016·Current Opinion in Lipidology·Kate HaralambosIan F W McDowell
Nov 27, 2016·European Journal of Preventive Cardiology·Katrina L EllisGerald F Watts
Oct 26, 2016·Journal of Lipid Research·Roopa MehtaCarlos A Aguilar-Salinas
May 4, 2017·Current Opinion in Lipidology·Colin A GrahamPadraig J Hart
Jun 24, 2017·European Journal of Preventive Cardiology·Ivan PećinŽeljko Reiner
Feb 7, 2018·The Journal of Clinical Endocrinology and Metabolism·Dick C ChanGerald F Watts
Dec 9, 2017·Nature Reviews. Disease Primers·Joep C DefescheAnthony S Wierzbicki
Oct 19, 2019·Clinical Transplantation·Nazli Gulsoy KirnapMehmet Haberal
Jul 4, 2020·Current Opinion in Lipidology·Handrean SoranUNKNOWN Simon Broome Familial Hyperlipidaemia Register Group
Aug 8, 2020·Journal of Atherosclerosis and Thrombosis·Hao WangZhou Zhou
Jul 8, 2016·Journal of Atherosclerosis and Thrombosis·Gerald F WattsUNKNOWN for tha members of the "Ten countries Study"
Jun 13, 2018·Scientific Reports·Sha LiJian-Jun Li
Oct 6, 2018·Current Vascular Pharmacology·Khalid Al-RasadiHani Altaradi
Jan 25, 2020·Nature Reviews. Cardiology·Gerald F WattsKausik K Ray
May 6, 2020·Annals of Clinical Biochemistry·Ben WilkinsonRousseau Gama
Jun 10, 2020·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Tim HollsteinElisabeth Steinhagen-Thiessen
Feb 24, 2016·Journal of Atherosclerosis and Thrombosis·Jing PangGerald F Watts
Apr 14, 2017·Current Cardiology Reports·Mahtab SharifiSteve E Humphries
May 11, 2016·European Heart Journal·Ezim Ajufo, Marina Cuchel
Apr 16, 2021·NPJ Genomic Medicine·Seyedmohammad SaadatagahIftikhar J Kullo
Oct 8, 2021·The Cochrane Database of Systematic Reviews·Nadeem QureshiJo Leonardi-Bee

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.